{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:15:56Z","timestamp":1781327756831,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12094-019-02034-w","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T06:30:58Z","timestamp":1547706658000},"page":"1135-1141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-5264","authenticated-orcid":false,"given":"T.","family":"Assi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Le Cesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Faron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Honart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hadiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Camuzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"LeP\u00e9choux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"2034_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jviscsurg.2015.05.001","volume":"152","author":"C Honore","year":"2015","unstructured":"Honore C, M\u00e9eus P, Stoeckle E, Bonvalot S. Soft tissue sarcoma in France in 2015: epidemiology, classification and organization of clinical care. J Visc Surg. 2015;152:223\u201330.","journal-title":"J Visc Surg"},{"key":"2034_CR2","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ejca.2012.09.011","volume":"49","author":"CA Stiller","year":"2013","unstructured":"Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2013;49:684\u201395.","journal-title":"Eur J Cancer"},{"key":"2034_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S1470-2045(17)30334-0","volume":"18","author":"A Gronchi","year":"2017","unstructured":"Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18:812\u201322.","journal-title":"Lancet Oncol"},{"key":"2034_CR4","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1200\/JCO.2011.37.7218","volume":"30","author":"A Gronchi","year":"2012","unstructured":"Gronchi A, Frustaci S, Mercuri M, Martin J, Lopez-Pousa A, Verderio P, et al. Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. J Clin Oncol. 2012;30:850\u20136.","journal-title":"J Clin Oncol"},{"key":"2034_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","volume":"15","author":"I Judson","year":"2014","unstructured":"Judson I, Verweij J, Gelderblom H, Hartmann JT, Sch\u00f6ffski P, Blay J-Y, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15:415\u201323.","journal-title":"Lancet Oncol"},{"key":"2034_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1200\/JCO.1992.10.1.52","volume":"10","author":"D Lienard","year":"1992","unstructured":"Lienard D, Ewalenko P, Delmotte J-J, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol. 1992;10:52\u201360.","journal-title":"J Clin Oncol"},{"key":"2034_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1053\/ejso.2000.0979","volume":"26","author":"FJ Lejeune","year":"2000","unstructured":"Lejeune FJ, Pujol N, Lienard D, Mosimann F, Raffoul W, Genton A, et al. Limb salvage by neoadjuvant isolated perfusion with TNF\u03b1 and melphalan for non-resectable soft tissue sarcoma of the extremities. Eur J Surg Oncol EJSO. 2000;26:669\u201378.","journal-title":"Eur J Surg Oncol EJSO"},{"key":"2034_CR8","volume-title":"World Health Organization Classification of tumours of soft tissue and bone","author":"CDM Fletcher","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. World Health Organization Classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.","edition":"4"},{"key":"2034_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijc.2910330108","volume":"33","author":"M Trojani","year":"1984","unstructured":"Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, De Mascarel A, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37\u201342.","journal-title":"Int J Cancer"},{"key":"2034_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"J Wieberdink","year":"1982","unstructured":"Wieberdink J, Benckhuysen C, Braat RP, Van Slooten EA, Olthuis GAA. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol. 1982;18:905\u201310.","journal-title":"Eur J Cancer Clin Oncol."},{"key":"2034_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/00000658-199612000-00011","volume":"224","author":"AM Eggermont","year":"1996","unstructured":"Eggermont AM, Koops HS, Klausner JM, Kroon BB, Schlag PM, Li\u00e9nard D, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg. 1996;224:756.","journal-title":"Ann Surg."},{"key":"2034_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205.","journal-title":"Ann Surg"},{"key":"2034_CR13","unstructured":"Health UD of, Services H. Common terminology criteria for adverse events (CTCAE) version 4.0. Natl Inst Health Natl Cancer Inst. 2009;4."},{"key":"2034_CR14","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","volume":"359","author":"B O\u2019Sullivan","year":"2002","unstructured":"O\u2019Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235\u201341.","journal-title":"Lancet"},{"key":"2034_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/(SICI)1096-9098(199602)61:2<90::AID-JSO2>3.0.CO;2-M","volume":"61","author":"EY Cheng","year":"1996","unstructured":"Cheng EY, Dusenbery KE, Winters MR, Thompson RC. Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol. 1996;61:90\u20139.","journal-title":"J Surg Oncol"},{"key":"2034_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1053\/ejso.1999.0687","volume":"25","author":"J Bickels","year":"1999","unstructured":"Bickels J, Manusama ER, Gutman M, Eggermont AMM, Kollender Y, Abu-Abid S, et al. Isolated limb perfusion with tumour necrosis factor-\u03b1 and melphalan for unresectable bone sarcomas of the lower extremity. Eur J Surg Oncol EJSO. 1999;25:509\u201314.","journal-title":"Eur J Surg Oncol EJSO."},{"key":"2034_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1245\/s10434-008-0277-4","volume":"16","author":"F Grabellus","year":"2009","unstructured":"Grabellus F, Kraft C, Sheu S-Y, Ebeling P, Bauer S, Lendemans S, et al. Evaluation of 47 soft tissue sarcoma resection specimens after isolated limb perfusion with TNF-\u03b1 and melphalan: histologically characterized improved margins correlate with absence of recurrences. Ann Surg Oncol. 2009;16:676\u201386.","journal-title":"Ann Surg Oncol"},{"key":"2034_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/jso.21885","volume":"103","author":"ML Hoven-Gondrie","year":"2011","unstructured":"Hoven-Gondrie ML, Bastiaannet E, van Ginkel RJ, Suurmeijer AJ, Hoekstra HJ. TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome. J Surg Oncol. 2011;103:648\u201355.","journal-title":"J Surg Oncol"},{"key":"2034_CR19","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/cncr.11648","volume":"98","author":"EM Noorda","year":"2003","unstructured":"Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BB. Isolated limb perfusion with tumor necrosis factor-\u03b1 and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer. 2003;98:1483\u201390.","journal-title":"Cancer"},{"key":"2034_CR20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/jso.23200","volume":"106","author":"NH Trabulsi","year":"2012","unstructured":"Trabulsi NH, Patakfalvi L, Nassif MO, Turcotte RE, Nichols A, Meguerditchian AN. Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials. J Surg Oncol. 2012;106:921\u20138.","journal-title":"J Surg Oncol"},{"key":"2034_CR21","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/jso.23591","volume":"109","author":"J Jakob","year":"2014","unstructured":"Jakob J, Tunn P-U, Hayes AJ, Pilz LR, Nowak K, Hohenberger P. Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection. J Surg Oncol. 2014;109:786\u201390.","journal-title":"J Surg Oncol"},{"key":"2034_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1245\/s10434-010-1400-x","volume":"18","author":"JP Deroose","year":"2011","unstructured":"Deroose JP, Burger JW, van Geel AN, Den Bakker MA, de Jong JS, Eggermont AM, et al. Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients? Ann Surg Oncol. 2011;18:321\u20137.","journal-title":"Ann Surg Oncol"},{"key":"2034_CR23","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1200\/JCO.2011.35.6618","volume":"29","author":"JP Deroose","year":"2011","unstructured":"Deroose JP, Eggermont AM, van Geel AN, Burger JW, den Bakker MA, de Wilt JH, et al. Long-term results of tumor necrosis factor \u03b1\u2013and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas. J Clin Oncol. 2011;29:4036\u201344.","journal-title":"J Clin Oncol"},{"key":"2034_CR24","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1245\/s10434-017-6109-7","volume":"24","author":"MG Neuwirth","year":"2017","unstructured":"Neuwirth MG, Song Y, Sinnamon AJ, Fraker DL, Zager JS, Karakousis GC. isolated limb perfusion and infusion for extremity soft tissue sarcoma: a contemporary systematic review and meta-analysis. Ann Surg Oncol. 2017;24:3803\u201310.","journal-title":"Ann Surg Oncol"},{"key":"2034_CR25","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1245\/s10434-009-0733-9","volume":"16","author":"S Bonvalot","year":"2009","unstructured":"Bonvalot S, Rimareix F, Causeret S, Le P\u00e9choux C, Boulet B, Terrier P, et al. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1\u00a0mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol. 2009;16:3350\u20137.","journal-title":"Ann Surg Oncol"},{"key":"2034_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-006-9251-1","volume":"14","author":"E Pennacchioli","year":"2007","unstructured":"Pennacchioli E, Deraco M, Mariani L, Fiore M, Mussi C, Collini P, et al. Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution. Ann Surg Oncol. 2007;14:553\u20139.","journal-title":"Ann Surg Oncol"},{"key":"2034_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1129::AID-CNCR11>3.0.CO;2-1","volume":"79","author":"M Gutman","year":"1997","unstructured":"Gutman M, Inbar M, Lev-Shlush D, Abu-Abid S, Mozes M, Chaitchik S, et al. High dose tumor necrosis factor-\u03b1 and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >\u200990% response rate and limb preservation. Cancer. 1997;79:1129\u201337.","journal-title":"Cancer"},{"key":"2034_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jso.21081","volume":"98","author":"S Cherix","year":"2008","unstructured":"Cherix S, Speiser M, Matter M, Raffoul W, Li\u00e9nard D, Theumann N, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients. J Surg Oncol. 2008;98:148\u201355.","journal-title":"J Surg Oncol"},{"key":"2034_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/cncr.21547","volume":"106","author":"DJ Grunhagen","year":"2006","unstructured":"Grunhagen DJ, de Wilt JH, Graveland WJ, van Geel AN, Eggermont AM. The palliative value of tumor necrosis factor \u03b1-based isolated limb perfusion in patients with metastatic sarcoma and melanoma. Cancer. 2006;106:156\u201362.","journal-title":"Cancer"},{"key":"2034_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1200\/JCO.2002.20.3.791","volume":"20","author":"MW Kattan","year":"2002","unstructured":"Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791\u20136.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-019-02034-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02034-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02034-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T19:14:39Z","timestamp":1579202079000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-019-02034-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2034"],"URL":"https:\/\/doi.org\/10.1007\/s12094-019-02034-w","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"14 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"An approval of the institutional ethics board at Gustave Roussy was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}